Hereditary Cancer Education

The Hereditary Cancer Program provides a range of learning opportunities (continuing education and professional development) for current and future health care professionals with an interest in hereditary cancer.

Rounds

The objectives of Hereditary Cancer Rounds are to:

Enhance knowledge of the genetic basis, prognosis, treatment and screening of hereditary cancer
Promote information exchange between disciplines
Provide opportunity to share knowledge, perspectives and experience between specialists who provide care for individuals and families with hereditary cancer

Hereditary Cancer Rounds are offered on the 2nd Friday of the month (except July/August), 9:00 am-10:00 am PST and are open to any health care professional who provides care for people with hereditary cancer, and/or has interest in cancer genetics.

The BC Cancer Hereditary Cancer Program Education Rounds is a self-approved group learning activity (Section 1) as defined by the Maintenance of Certification Program of the Royal College of Physicians and Surgeons of Canada.

NSGC has authorized up to 1.0 CEUs or 10 Category 1 contact hours for this presentation series.

How to attend

Hereditary Cancer Rounds can be attended online by Zoom. For more information on how to attend, click "+" on the option below.

To find out about upcoming rounds and meetings, email genetic counsellor Faith Cheung at faith.cheung@bccancer.bc.ca to join the HCP Rounds email list.

By Zoom

Remote access via Zoom is available on both personal and work computers.

For the 2023/2024 series:

Webinar ID: 674 9917 9975
Webinar Passcode: 820019

To register for the series, please visit: https://phsa.zoom.us/webinar/register/WN_0I1WIKBcQIGsiVHY1IEu9Q

Recent rounds

To view recordings/presentation slides of recent HCP rounds, please click on the link(s) below.

01/12/24: Opportunistic and Population Genomic Screening
03/08/24: Optimizing Pregnancy Outcomes in Breast Cancer Patients
04/12/24: Providing Care for Adolescents With, and At-Risk For, Genetic Conditions
05/10/24: Personalized ctDNA Testing for MRD Assessment to Inform Treatment in Patients with Solid Tumours
06/14/24: Trauma-Informed Approaches in Cancer Care
09/13/24: Checking CHEK2 - Cancer Phenotypes Among Frequent CHEK2 Variants and Implications for Clinical Care
10/11/24: Pediatric Cancer Predisposition Pathways
11/08/24: ATRIP: A Novel Breast Cancer Susceptibility Gene
12/06/24: Breast Screening: Who, When, How?

Archives

To review archived Hereditary Cancer Rounds, click on the year below. Available presentation slides/videos can be accessed via the description link:

2023

Date	Description
02/10/23	Supporting Young Adults with Advanced Cancer: Insights and Recommendations from a Multi-Phase Qualitative Study
03/10/23	Two and a half MEN...and then some: Approaches to Hereditary Endocrine Neoplasia Syndromes
04/14/23	Parent-of-origin-aware genomic analysis in Hereditary Cancer
05/12/23	Delivering cancer genomics digitally: evidence, policy & equity
06/09/23	Describing the Real World Experience of Implementing a Pre-test Genetic Counselling Portal within a Provincial Hereditary Cancer Program
09/08/23	VHL Disease: From Gene Mutation to Comprehensive Management Strategies
10/13/23	Talking to Patients and Families about 21st Century Palliative Care

2022

Date	Description

02/11/22	Population-Based Hereditary Cancer Care in BC and Yukon: A Changing Landscape
03/11/22	Outcomes of a randomized trial studying the Accessible, Relational, Inclusive and Actionable (ARIA) genetic counseling approach
04/08/22	Hereditary Hematologic Malignancies
06/10/22	Knowledge Translation for Personalized OncoGenomics (POG): How to Make Precision Cancer Medicine Understandable
09/09/22	Indigenous Cancer Experience in BC
10/21/22	The British Columbia Hereditary Cancer Follow-up Initiative (HCFI): A Provincial Approach to Support for People Living with Hereditary Cancer Syndromes
11/18/22	Paired DNA-RNA germline sequencing in 43,000 individuals tested for hereditary cancer: Initial lessons and next steps
12/09/22	Identification and Management of Hereditary Paraganglioma/Pheochromocytoma

2021

Date	Description
02/12/21	Bringing Genetics into Mainstream Medicine
03/12/21	Ethical considerations in cancer care and research
04/09/21	Cancer Genetics, Part 2- better than part 1!
05/14/21	Cancer Risk Assessment in Non-Binary and Transgender Youth
06/11/21	Clinical utility of germline hereditary cancer syndrome testing
09/10/21	Personalized Risk Assessment for Prevention and Early Detection of Breast Cancer: Integration and Implementation (PERSPECTIVE I&I)
10/08/21	Beyond Support Groups: The Role of Two Patient Organizations in Rare Disorders
11/12/21	Evolution of universal screening for Lynch syndrome
12/10/21	CATCHing Hidden Variants in High-Risk Cancer Families: Advancements in HBOC Research and Genetic Testing

2020

Date	Description
01/10/20	Genetic Testing at Time of Breast Cancer Diagnosis: Clinical Implications and Patient Perspectives
02/14/20	Direct-to-Consumer; Private-Pay; Patient- or Consumer-Initiated; Physician-Mediated….. Oh my! Out-of-pocket genetic testing: What’s in the name?
03/13/20	The Story of MSH2 c.-82G>C: A Newfoundland Founder Mutation
06/12/20	Precision Genomics in the WISDOM Pragmatic Clinical Trial: An "Embedded" ELSI Study of Risk-based Breast Cancer Screening
09/22/20	The Genetic Non-Discrimination Act upheld by the Supreme Court: Does this mean the end of genetic discrimination in Canada?
10/9/20	Life on E(z) street: low-hanging fruit flies
11/13/20	Rhabdoid Tumour Predisposition Syndrome

2019

Date	Description
01/11/19	Non-Surgical Breast Cancer Prevention in BRCA Mutation Carriers: What do we know?
02/08/19	Prostate Cancer Genetic Counselling: Current Status and Evolving Trends (slides)
03/08/19	Genetic Testing for Hereditary Cancer: Started with the Germline Now We're Here
04/16/19	Duty to warn: should we consider genetic conditions reportable?
06/14/19	Mismatch Repair Deficiency as a Target for Immunotherapy in Gastrointestinal Cancers
10/11/19	Identifying and Screening High Risk Patients for Pancreatic Cancer
11/8/19	Oncology Clinic-based Hereditary Cancer Genetic Testing and Evaluating Patient Psychological Responses to Genetic Counselling
12/13/19	Making Sense of MEN

2018

Date	Description
01/12/18	Homologous Recombination Deficiency in Breast Cancer
02/09/18	Histology based referral for BRCA1 and BRCA2 ovarian cancer patients and risk-reducing interventions in BRCA positive patients
03/09/18	INSPIRE HEALTH – Supportive Cancer Care:A Resource for Healthcare Providers,Patients & their Families
04/13/18	Pathology perspective of colonic polyposis syndromes:When are too many colonic polyps too many?
05/11/18	Highlights from the Ohio Colorectal Cancer Prevention Initiative
09/14/18	Familial Brain Syndrome Tumours
11/09/18	Hereditary Prostate Cancer
12/14/18	CNV Prevalence in Hereditary Cancer Testing

2017

Date	Description
01/13/17	Cancer Genetics, the Tumour and Germline: Two Siblings Meet Again
02/10/17	The Intersection of Germline and Somatic Genetic & Genomic Testing
05/12/17	Ovarian Cancer: Clinical Progress Update
06/09/17	Does Preference-based Utility for Genomic Knowledge Have a Role in Decision-making?
09/08/17	The Gamut of Breast Imaging Beyond High Risk Surveillance
10/13/17	BC Cancer Hereditary High Risk Clinic: Overview and Outcomes
11/10/17	A New Approach to Genetic Counselling and Testing: Key Clinical Findings
12/08/17	Familial Pancreatic Cancer Program - First Year Outcomes

2016

Date	Description
01/08/16	Issues in Predictive Testing for Adult-onset Conditions in Minors
02/12/16	Invitae’s Approach to Panel Curation and Variant Interpretation
03/11/16	Germline Findings in Tumour Sequencing - What is Revealed and What Can We Learn
04/08/16	Implementing the New ACMG Guidelines for Sequence Interpretation for Variants Identified by the Cancer Genetics Lab - Hereditary Cancer Panel
05/13/16	Fertility Preservation in Female Cancer Patients of Reproductive Age: Professional Perspectives and Development of an Informational Tool
06/10/16	Genetic Counselling with Adolescents: Drawing on the Lighthouse Model of Promoting Resilience
10/03/16	Breast Cancer Genetics and Health Care Policy
10/14/16	Dissecting the Clinical Genomics of Advanced Prostate Cancer Through Liquid Biopsy
12/09/16	Canadian Legislation on Prevention of Genetic Discrimination Update for Genetics and Oncology Professionals

2015

Date	Description
01/09/15	Genetic Testing and Life Insurance
02/13/15	Next-generation Sequencing in Clinical Research and Practice
03/13/15	BRCA Mutation Prediction Models
04/10/15	Hereditary Kidney Cancer: Current Status and Insights from the KCRNC
05/08/15	Hereditary Cancer Testing in the Edmonton Molecular Diagnostic Lab: The Good, the Bad and the Interesting
06/12/15	Ethical Implications of Whole Genome Sequencing for Oncology Patients
10/09/15	Updates from the Australian 'Familial Aspects of Cancer: Research and Practice' Meeting (August 2015)
11/13/15	Cancer Risk Education with a Diverse Low-Income, Low-Health Literacy & Limited English Proficiency Population
12/11/15	Fanconi Anemia - Breaking Apart the Complex Cancer and Genetic Counselling Issues

2014

Date	Description
03/07/14	Direct to Consumer Genetic Testing: The Good, the Bad and the Ugly from an Ethicist's Perspective
03/13/14	Special Grand Rounds - Personalized Genomics and Cancer Prevention
04/11/14	Confidence Intervals: Inspiring Confidence or Confusion?
05/09/14	5th International Symposium on Hereditary Breast and Ovarian Cancer - Twenty Years of Advances
06/27/14	The Lymphoma Family Study
07/11/14	Familial Cancer Research at the Peter MacCallum Cancer Centre
09/26/14	Beyond BRCA for Hereditary Cancer Syndromes
10/10/14	Screening for Muir-Torre Syndrome Using Mismatch Repair Protein Immunohistochemistry of Sebaceous Neoplasms
11/21/14	Management of Hereditary Breast Cancer
12/12/14	Changing the Paradigm of Pancreatic Cancer: New Testing, New Treatment, New Optimism

2013

Date	Description
01/11/13	Clinical Outcomes & Quality of Life in CDH1 Mutation Carriers after Prophylactic Gastrectomy
02/08/13	Preimplantation Genetic Diagnosis
03/08/13	Multiple Endocrine Neoplasia, Type 1 (Burin): Lessons for Newfoundland and Elsewhere
04/19/13	The Use of Whole Genome Sequencing in the Management of Oncologic Patients
05/10/13	BAP1 Tumour Predisposition Syndrome
06/14/13	Gemline MLH1 Hypermethylation: Case Discussion and Review, and Observations on Practicing Across the Border
10/11/13	I Contain Multitudes: Mosaicism and Chimerism in Development and Disease
11/29/13	Updates from the 2013 Annual Meeting of the Collaborative Group of the Americas on Inherited Colorectal Cancer
12/13/13	Looking Back with Fondness

2012

Date	Description
02/10/12	Telomeres & Hereditary Cancer
03/09/12	British Columbia's Personalized Medicine Initiative: Next Generation Sequencing & the Personalization of Cancer Control
04/13/12	Hereditary Cancer Program's High-Risk (Breast) Clinic: Experience to Date
09/14/12	4th International Symposium on Hereditary Breast & Ovarian Cancer - From Theory to Practice
10/12/12	CDKN2A: Past, Present and Future
11/09/12	2012 Canadian Assoc of Genetic Counsellors Short Course & Annual Education Conference
12/14/12	16th Annual Meeting of the Collaborative Group of the Americas on Inherited Colorectal Cancer (CGA-ICC, Boston)

2011

Date	Description
01/14/11	Determination of a Family's Tie Between Bones and Blindness: A Next Generation Sequencing Approach
02/11/11	Reducing the Burden of Gynecologic Cancers in Hereditary Cancer Syndromes
03/11/11	Can We Define Patients Who Will Respond to PARP Inhibitors?
04/08/11	Management of Proliferative Lesions of the Breast (ADH, ALH, DIN1a & b, LCIS, DCIS)
05/13/11	Incident Testing for Lynch Syndrome in Colorectal Cancer (CRC) Under Age 50 in BC
05/13/11	Exploring the Lived Experience After a Diagnosis of Li Fraumeni Syndrome (LFS)
06/10/11	Second-Generation Sequencing for Clinical Diagnostics
09/09/11	BRCA1/2 UCV Assessment: Uncertainty Going Backwards & Forwards
10/14/11	Hereditary Pheochromocytoma & Paraganglioma: Updates from 3rd International Symposium
11/25/11	Highlights from Recent Conferences: National Society of Genetic Counselors, 30th Annual Conference & Collaborative Group of the Americas on Inherited Colorectal Cancer (CGA-ICC), 15th Annual Meeting
12/09/11	Highlights from Recent Conferences: 12th International Congress of Human Genetics and Canadian Association of Genetic Counsellors

2010

Date	Description
03/12/10	Updates: Lynch Syndrome in BC and Colon Check
04/09/10	Expedited BRCA1/2 Testing in Incident Breast Cancer Care
05/14/10	Pathology of Hereditary Ovarian Cancer
06/11/10	Pancreatic Cancer - Progress - Finally
06/11/10	Psychosocial Impact of Genetic Testing in Cancer: Screening for Those who Require Additional Psychosocial Support
09/10/10	Hyperplastic Polyposis and MYH
11/12/10	Highlights from Recent Conferences
12/10/10	Highlights from Recent Conferences

Other learning opportunities

Hereditary Cancer Program (HCP) team members are pleased to provide a range of learning opportunities for current and future health care professionals with an interest in hereditary cancer. These include:

HCP introduction for medical residents/fellows

Family practice
Gynecology
Oncology – medical, radiation, surgical
Other

Clinical rotations for genetic counselling students, medical genetics residents/fellows
Job shadowing for future genetic counsellors
Volunteering with HCP
Presentations for professional and community education events

To contact HCP with a specific request, click here to send an email.

Tab Heading

Provincial Health Services Authority